91 related articles for article (PubMed ID: 10228661)
1. Coronary artery disease and homocysteine: a case study.
Shinnick MA; Holmes LI
Am J Crit Care; 1999 May; 8(3):193-6. PubMed ID: 10228661
[No Abstract] [Full Text] [Related]
2. Homocysteine and the heart.
Turner SL; Bechtel GA
Adv Nurse Pract; 1999 Mar; 7(3):71-3. PubMed ID: 10373803
[No Abstract] [Full Text] [Related]
3. Homocysteine: the latest risk factor for heart disease.
Reeder SJ; Hoffmann RL; Magdic KS; Rodgers JM
Dimens Crit Care Nurs; 2000; 19(1):22-8. PubMed ID: 10876482
[TBL] [Abstract][Full Text] [Related]
4. Reducing coronary artery disease by decreasing homocysteine levels.
Coffey M; Crowder GK; Cheek DJ
Crit Care Nurse; 2003 Feb; 23(1):25-30. PubMed ID: 12640957
[No Abstract] [Full Text] [Related]
5. [Hyperhomocysteinemia. A new coronary risk factor].
Zacarías-Castillo R; Hernández-Rebollar AE; Zajarias-Rabchinskey A; González-Bárcena D
Gac Med Mex; 2001; 137(4):335-45. PubMed ID: 11519357
[TBL] [Abstract][Full Text] [Related]
6. Homocysteine--relevant for atherogenesis?
Kircher T; Sinzinger H
Wien Klin Wochenschr; 2000 Jun; 112(12):523-32. PubMed ID: 10953870
[TBL] [Abstract][Full Text] [Related]
7. Evidence suggests diabetes outcomes linked to homocysteine.
Clement L
Nephrol News Issues; 2003 Dec; 17(13):16-7. PubMed ID: 14694857
[No Abstract] [Full Text] [Related]
8. [Plasma homocysteine levels in patients with ischemic heart disease].
Márk L; Erdei F; Márki-Zay J; Nagy E; Kondacs A; Katona A
Orv Hetil; 2001 Jul; 142(30):1611-5. PubMed ID: 11519232
[TBL] [Abstract][Full Text] [Related]
9. Hyperhomocysteinemia: an additional cardiovascular risk factor.
Fanapour PC; Yug B; Kochar MS
WMJ; 1999 Dec; 98(8):51-4. PubMed ID: 10639897
[TBL] [Abstract][Full Text] [Related]
10. High plasma homocysteine is associated with the risk of coronary artery disease independent of methylenetetrahydrofolate reductase 677C-->T genotypes.
Lin PT; Huang MC; Lee BJ; Cheng CH; Tsai TP; Huang YC
Asia Pac J Clin Nutr; 2008; 17(2):330-8. PubMed ID: 18586656
[TBL] [Abstract][Full Text] [Related]
11. Preventing restenosis in CAD patients. Folate therapy reduces homocysteine--and risk.
All AK; Bobadilla RV
Adv Nurse Pract; 2004 Mar; 12(3):79-82. PubMed ID: 15038191
[No Abstract] [Full Text] [Related]
12. [Cellular and molecular mechanism of cardiovascular disease resulting from hyperhomocysteinemia].
Gao L; Tang CS
Sheng Li Ke Xue Jin Zhan; 2002 Oct; 33(4):335-8. PubMed ID: 12650071
[No Abstract] [Full Text] [Related]
13. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M
Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738
[TBL] [Abstract][Full Text] [Related]
14. [Hyperhomocysteinemia as a vascular risk factor in chronic hemodialysis patients].
Trimarchi H; Young P; Díaz ML; Schropp J; Forrester M; Freixas E
Medicina (B Aires); 2005; 65(6):513-7. PubMed ID: 16433478
[TBL] [Abstract][Full Text] [Related]
15. Homocysteine and coronary risk.
Seshadri N; Robinson K
Curr Cardiol Rep; 1999 Jul; 1(2):91-8. PubMed ID: 10980826
[TBL] [Abstract][Full Text] [Related]
16. Rationale and design for the CARDIOVIT Study (Cardiovit, Atherosclerotic vascular disease and hypeRhomocysteinemia: an epiDemiological study in Indians, additionally evaluating the effect of Oral VITamin supplementation).
Shenoy KT; Lena KB; Sali N; Syam S; Shenoy ST; Rajadhyaksha VD; Pai GP; Shaikh AA;
Curr Med Res Opin; 2006 Apr; 22(4):641-8. PubMed ID: 16684424
[TBL] [Abstract][Full Text] [Related]
17. No effect of folic acid on markers of endothelial dysfunction or inflammation in patients with type 2 diabetes mellitus and mild hyperhomocysteinaemia.
Spoelstra-de MA; Brouwer CB; Terheggen F; Bollen JM; Stehouwer CD; Smulders YM
Neth J Med; 2004; 62(7):246-53. PubMed ID: 15554600
[TBL] [Abstract][Full Text] [Related]
18. Homocysteine--a novel risk factor for vascular disease.
Chambers JC; Seddon MD; Shah S; Kooner JS
J R Soc Med; 2001 Jan; 94(1):10-3. PubMed ID: 11220060
[No Abstract] [Full Text] [Related]
19. [Hyperhomocysteinemia is frequent in coronary disease patients. Study of 202 patients].
Fernández-Miranda C; Aranda JL; Gómez González P; Díaz-Rubio P; Estenoz J; Gómez de la Cámara A
Med Clin (Barc); 1999 Oct; 113(11):407-10. PubMed ID: 10562951
[TBL] [Abstract][Full Text] [Related]
20. Preventive health care, 2000 update: screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events. The Canadian Task Force on Preventive Health Care.
Booth GL; Wang EE
CMAJ; 2000 Jul; 163(1):21-9. PubMed ID: 10920726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
